Phase 1/2 Study of Treatment Response With VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor, in Patients with Thyroid Eye Disease (TED) Conferences

Overview
Research
Additional Document Info
View All

authors

Turbin, Roger
Douglas, Raymond
Ugradar, Shoaib
Cockerham, Kimberly
Schiffman, Jade
Nijhawan, Navdeep
O'Shaughnessy, Denis
Summerfelt, Rochelle
She, Angela
Katz, Barrett

status

published

publication date

June 2023

has subject area

06 Biological Sciences (FoR)
11 Medical and Health Sciences (FoR)
Ophthalmology & Optometry (Science Metrix)

published in

Investigative Ophthalmology and Visual Science Journal

presented at event

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO) Conference